Anebulo Pharmaceuticals, Inc.

NasdaqCM:ANEB 株式レポート

時価総額:US$49.3m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Anebulo Pharmaceuticals マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Richie Cunningham

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権n/a
経営陣の平均在職期間2.1yrs
取締役会の平均在任期間3.3yrs

経営陣の近況

Recent updates

Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Jun 22
Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?

Feb 18
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?

Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?

Jul 03
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?

Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Mar 07
Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth

Nov 19
We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth

Anebulo Pharmaceuticals to launch private investment in public equity financing

Sep 26

Anebulo Pharmaceuticals GAAP EPS of -$0.10 misses by $0.03

Sep 09

Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Jun 28
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Mar 15
Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Nov 04
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Anebulo Pharmaceuticals reports FQ3 results

Jun 21

CEO(最高経営責任者

Richie Cunningham (53 yo)

less than a year

在職期間

Mr. Richard Anthony Cunningham, also known as Richie, is Chief Executive Officer and Director of Anebulo Pharmaceuticals, Inc. since October 2023. He served as Chief Executive Officer and Director at Tyme...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Joseph Lawler
Founder & Chairman4.2yrsUS$11.00k46.27%
$ 22.8m
Kenneth Cundy
Chief Scientific Officer2.1yrsUS$495.63k0%
$ 0
Richard Cunningham
CEO & Directorless than a yearデータなしデータなし
Daniel George
Principal Accounting Officerless than a yearデータなしデータなし
Scott Anderson
Head of Investor Relations & Public Affairs2.4yrsデータなしデータなし

2.1yrs

平均在職期間

53.5yo

平均年齢

経験豊富な経営陣: ANEBの経営陣は 経験豊富 であると考えられます ( 2.1年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Joseph Lawler
Founder & Chairman4.2yrsUS$11.00k46.27%
$ 22.8m
Richard Cunningham
CEO & Directorless than a yearデータなしデータなし
Bimal Shah
Independent Directorless than a yearデータなしデータなし
Kenneth Lin
Lead Independent Director3.3yrsUS$1.00k0%
$ 0
Areta Kupchyk
Independent Director3.2yrsUS$11.00k0%
$ 0
Jason Aryeh
Independent Director3.3yrsUS$21.00k0%
$ 0
Nathaniel Calloway
Independent Director1.7yrsUS$79.75kデータなし
Aron English
Independent Director4yrsUS$1.00k17.95%
$ 8.8m
Andrew Monte
Member of Scientific Advisory Board3.4yrsデータなしデータなし
Arjun Chanmugam
Member of Scientific Advisory Board3.4yrsデータなしデータなし

3.3yrs

平均在職期間

52yo

平均年齢

経験豊富なボード: ANEBの 取締役会経験豊富 であると考えられます ( 3.3年の平均在任期間)。